FDA Drug Information Updates
by ReachMD
July 31, 2018 2:00 pm
Experts from the U.S. Food and Drug Administration (FDA) discuss important new drug information as well as urgent insights about approved drug products.
Recent Episodes
The FAERS Public Dashboard and its Value to the Pharmaceutical Industry
6 years agoFDA Warns of Serious Immune Reaction with Seizure/BPD Medicine Lamotrigine (Lamictal)
7 years agoFDA D.I.S.C.O.: First Biosimilar Approval for the Treatment of Cancer
7 years agoFDA Requires New Class Warnings for All Gadolinium-Based Contrast Agents
7 years agoFDA Review: Adding LABAs to ICS Treatment Does Not Significantly Increase Serious Asthma Outcomes Risk
7 years agoPinpointing the Top Questions about Biosimilars in Rheumatology
7 years agoThe FDA's Adverse Event Reporting System (FAERS) Public Dashboard
7 years agoFDA D.I.S.C.O.: L-Glutamine for Sickle Cell Disease
7 years agoFDA D.I.S.C.O.: Osimertinib for Non-Small Cell Lung Cancer
7 years agoFDA D.I.S.C.O.: Two Approvals for ALK-Positive Non-Small Cell Lung Cancer
7 years ago